Hypersensitivity to the active substance or to any of the excipients. Second and third trimesters of pregnancy. Biliary obstruction. The concomitant use of Olmesartan with aliskiren-containing products is contraindicated in patients with diabetes mellitus or renal impairment (GFR < 60 mL/min/1.73 m2).